Bausch Health
BHC
#4261
Rank
โ‚น229.74 B
Marketcap
โ‚น619.33
Share price
-1.30%
Change (1 day)
-4.53%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น87.96. In 2024 the company made an earnings per share (EPS) of -โ‚น10.88 an increase over its 2023 EPS that were of -โ‚น146.90.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-878.4%
2024-โ‚น10.88-92.59%
2023-โ‚น146.90160.89%
2022-โ‚น56.31-76.64%
2021-โ‚น241.0268.45%
2020-โ‚น143.08-68.91%
2019-โ‚น460.19-57.11%
2018-โ‚น1,073-272.22%
2017โ‚น623.06-199.29%
2016-โ‚น627.49798.7%
2015-โ‚น69.82-128.31%
2014โ‚น246.64-204.62%
2013-โ‚น235.76602.7%
2012-โ‚น33.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น86.14-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.76-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA